198 related articles for article (PubMed ID: 26677896)
1. Influence of pH modifiers on the dissolution and stability of hydrochlorothiazide in the bi- and three-layer tablets.
Blatnik SU; Dreu R; Srčič S
Acta Pharm; 2015 Dec; 65(4):383-97. PubMed ID: 26677896
[TBL] [Abstract][Full Text] [Related]
2. Poly (amidoamine) dendrimer-mediated hybrid formulation for combination therapy of ramipril and hydrochlorothiazide.
Singh MK; Pooja D; Kulhari H; Jain SK; Sistla R; Chauhan AS
Eur J Pharm Sci; 2017 Jan; 96():84-92. PubMed ID: 27614111
[TBL] [Abstract][Full Text] [Related]
3. From 'fixed dose combinations' to 'a dynamic dose combiner': 3D printed bi-layer antihypertensive tablets.
Sadia M; Isreb A; Abbadi I; Isreb M; Aziz D; Selo A; Timmins P; Alhnan MA
Eur J Pharm Sci; 2018 Oct; 123():484-494. PubMed ID: 30041029
[TBL] [Abstract][Full Text] [Related]
4. Cilazapril stability in the presence of hydrochlorothiazide in model mixtures and fixed dose combination.
Paszun SK; Stanisz BJ; Gradowska A
Acta Pol Pharm; 2013; 70(6):1079-85. PubMed ID: 24383331
[TBL] [Abstract][Full Text] [Related]
5. A new, rapid, stability-indicating UPLC method for separation and determination of impurities in amlodipine besylate, valsartan and hydrochlorothiazide in their combined tablet dosage form.
Vojta J; Jedlička A; Coufal P; Janečková L
J Pharm Biomed Anal; 2015 May; 109():36-44. PubMed ID: 25756663
[TBL] [Abstract][Full Text] [Related]
6. Detection of the diuretic hydrochlorothiazide in a doping control urine sample as the result of a non-steroidal anti-inflammatory drug (NSAID) tablet contamination.
Helmlin HJ; Mürner A; Steiner S; Kamber M; Weber C; Geyer H; Guddat S; Schänzer W; Thevis M
Forensic Sci Int; 2016 Oct; 267():166-172. PubMed ID: 27611956
[TBL] [Abstract][Full Text] [Related]
7. Effect of hydroxypropyl cellulose (HPC) on dissolution rate of hydrochlorothiazide tablets.
Desai D; Rinaldi F; Kothari S; Paruchuri S; Li D; Lai M; Fung S; Both D
Int J Pharm; 2006 Feb; 308(1-2):40-5. PubMed ID: 16321490
[TBL] [Abstract][Full Text] [Related]
8. A comparative study of modified starches in direct compression of a poorly water soluble drug (hydrochlorothiazide).
Okafor IS; Ofoefule SI; Udeala OK
Boll Chim Farm; 2001; 140(1):36-9. PubMed ID: 11338775
[TBL] [Abstract][Full Text] [Related]
9. The role of intra- and extragranular microcrystalline cellulose in tablet dissolution.
Li JZ; Rekhi GS; Augsburger LL; Shangraw RF
Pharm Dev Technol; 1996 Dec; 1(4):343-55. PubMed ID: 9552318
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Co-Crystallization of Olmesartan Medoxomil and Hydrochlorothiazide for Enhanced Dissolution Rate in Their Fixed Dose Combination.
Abdelquader MM; Essa EA; El Maghraby GM
AAPS PharmSciTech; 2018 Dec; 20(1):3. PubMed ID: 30560314
[TBL] [Abstract][Full Text] [Related]
11. Mini-tablet combination for sustained release of clonidine hydrochloride and hydrochlorothiazide: Preparation and pharmacokinetics in beagle dogs.
Xu B; Wang Y; Zhu H
Pharmazie; 2016 Feb; 71(2):76-83. PubMed ID: 27004371
[TBL] [Abstract][Full Text] [Related]
12. A novel three-layered tablet for extended release with various layer formulations and in vitro release profiles.
Park JS; Shim JY; Park JS; Choi YW; Jeong SH
Drug Dev Ind Pharm; 2011 Jun; 37(6):664-72. PubMed ID: 21449708
[TBL] [Abstract][Full Text] [Related]
13. The influence of swelling capacity of superdisintegrants in different pH media on the dissolution of hydrochlorothiazide from directly compressed tablets.
Zhao N; Augsburger LL
AAPS PharmSciTech; 2005 Sep; 6(1):E120-6. PubMed ID: 16353956
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of cellulose II powders as a potential multifunctional excipient in tablet formulations.
de la Luz Reus Medina M; Kumar V
Int J Pharm; 2006 Sep; 322(1-2):31-5. PubMed ID: 16828996
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive evaluation of layer separation tendency of novel three-layered tablets with geometric and mechanical properties.
Choi du H; Lim DG; Son HM; Jeong SH
Int J Pharm; 2014 Apr; 465(1-2):347-59. PubMed ID: 24530386
[TBL] [Abstract][Full Text] [Related]
16. Formulation, release characteristics and bioavailability of novel monolithic hydroxypropylmethylcellulose matrix tablets containing acetaminophen.
Cao QR; Choi YW; Cui JH; Lee BJ
J Control Release; 2005 Nov; 108(2-3):351-61. PubMed ID: 16154656
[TBL] [Abstract][Full Text] [Related]
17. Double-Layered Matrix of Shellac Wax-Lutrol in Controlled Dual Drug Release.
Phaechamud T; Choncheewa CE
AAPS PharmSciTech; 2016 Dec; 17(6):1326-1335. PubMed ID: 26694059
[TBL] [Abstract][Full Text] [Related]
18. Fosinopril and hydrochlorothiazide combination versus individual components: lack of a pharmacokinetic interaction.
Uderman HD; Much DR; Brennan J; Delaney CL; Morgenthien EA; Weaver J; Stouffer BC; Chang SY; VanHarken D; Liao W
Ann Pharmacother; 1999 May; 33(5):525-30. PubMed ID: 10369612
[TBL] [Abstract][Full Text] [Related]
19. Formulation development of metoprolol succinate and hydrochlorothiazide compression coated tablets.
Shah R; Parmar S; Patel H; Pandey S; Shah D
Curr Drug Deliv; 2013 Dec; 10(6):631-44. PubMed ID: 23017092
[TBL] [Abstract][Full Text] [Related]
20. Sucralose as co-crystal co-former for hydrochlorothiazide: development of oral disintegrating tablets.
Arafa MF; El-Gizawy SA; Osman MA; El Maghraby GM
Drug Dev Ind Pharm; 2016 Aug; 42(8):1225-33. PubMed ID: 26555927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
